This brand name is authorized in Austria, Brazil, Croatia, Estonia, Finland, France, Ireland, Japan, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.
The drug TARGOCID contains one active pharmaceutical ingredient (API):
1
|
UNII
4U3D3YY81M - TEICOPLANIN
|
|
Teicoplanin inhibits the growth of susceptible organisms by interfering with cell-wall biosynthesis at a site different from that affected by beta-lactams. Peptidoglycan synthesis is blocked by specific binding to D-alanyl-D-alanine residues. |
|
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| TARGOCID Powder for solution for injection, infusion or oral solution | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| J01XA02 | Teicoplanin | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01X Other antibacterials → J01XA Glycopeptide antibacterials |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| BR | Câmara de Regulação do Mercado de Medicamentos | 576720060071317, 576720060071417 |
| EE | Ravimiamet | 1682052, 1787429 |
| ES | Centro de información online de medicamentos de la AEMPS | 58921, 58922 |
| FI | Lääkealan turvallisuus- ja kehittämiskeskus | 539510, 539528 |
| FR | Base de données publique des médicaments | 60462328, 64077917, 69006105 |
| GB | Medicines & Healthcare Products Regulatory Agency | 41813, 41827 |
| HR | Agencija za lijekove i medicinske proizvode | HR-H-411114699 |
| IE | Health Products Regulatory Authority | 49352, 49379 |
| JP | 医薬品医療機器総合機構 | 6119401D1035 |
| MT | Medicines Authority | MA1359/03901 |
| MX | Comisión Federal para la Protección contra Riesgos Sanitarios | 528M94 |
| NL | Z-Index G-Standaard, PRK | 31895, 33588 |
| NZ | Medicines and Medical Devices Safety Authority | 6679 |
| PL | Rejestru Produktów Leczniczych | 100065717, 100065723, 100386730, 100386841, 100410746, 100459001 |
| RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | W64490001, W64490002, W64490003, W64490004 |
| SG | Health Sciences Authority | 05117P |
| TN | Direction de la Pharmacie et du Médicament | 5933061H, 5933062H |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8699809790155, 8699809790209 |
| ZA | Health Products Regulatory Authority | 32/20.1.1/0337, Z/20.1.1/61, Z/34/159 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.